Sheel Biotech
SHEEL NSE
Sheel Biotech
Commercial ServicesNSE: SHEEL Diversified Services
Key Fundamentals
SMEDiversified ServicesCommercial ServicesMarket Cap
₹122 Cr
EBITDA
₹17.00 Cr
Return on Equity
9.26%
Debt to Equity
0.07
Book Value
₹62.40
EPS (TTM)
—
52W High
₹92.80
52W Low
₹37.80
Price-based figures as of 8 Oct 2026, 2:59 pm IST · TTM
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
4- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.96 times its book value
- Company has delivered good profit growth of 20.2% CAGR over last 5 years
Weaknesses
3- The company has delivered a poor sales growth of 11.8% over past five years.
- Company has a low return on equity of 13.0% over last 3 years.
- Company has high debtors of 205 days.
Growth Rate
Revenue Growth
8.21% higher than
3Y
Net Income Growth
9.26% lower than
3Y
Cash Flow Change
-306%
EBITDA Margin (Avg.)
1.32% higher than
3Y
Quarterly Results
| Particulars | Sep 2024 | Sep 2025 |
|---|---|---|
| Sales | 11 | 22 |
| Expenses | 14 | 20 |
| Operating Profit | -2 | 2 |
| OPM % | -22% | 8% |
| Other Income | 0 | 0 |
| Interest | 1 | 1 |
| Depreciation | 0 | 1 |
| PBT | -4 | 0 |
| Tax % | 3% | 24% |
| Net Profit | -4 | 0 |
| EPS in Rs | -2.53 | 0.13 |
Profit & Loss
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 63 | 84 | 89 | 103 | 102 | 110 |
| Expenses | 56 | 78 | 80 | 89 | 87 | 94 |
| Operating Profit | 7 | 6 | 9 | 14 | 15 | 16 |
| OPM % | 10% | 8% | 10% | 14% | 15% | 15% |
| Other Income | 0 | 0 | 0 | 0 | 1 | 1 |
| Interest | 1 | 1 | 2 | 1 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 |
| PBT | 5 | 5 | 6 | 12 | 13 | 14 |
| Tax % | 0% | 2% | 20% | 15% | 16% | 16% |
| Net Profit | 5 | 5 | 5 | 10 | 11 | 12 |
| EPS in Rs | 11.58 | 10.88 | 12.26 | 25.27 | 7.2 | 5.78 |
| Div. Payout % | 0% | 28% | 25% | 12% | 14% | 0% |
Balance Sheet
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 15 | 20 |
| Reserves | 53 | 56 | 59 | 69 | 69 | 107 |
| Borrowings | 21 | 24 | 19 | 24 | 17 | 9 |
| Other Liabilities | 4 | 10 | 11 | 10 | 10 | 10 |
| Total Liabilities | 82 | 93 | 94 | 106 | 111 | 146 |
| Fixed Assets | 8 | 8 | 8 | 7 | 7 | 9 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 3 |
| Investments | 0 | 1 | 1 | 1 | 1 | 1 |
| Other Assets | 75 | 84 | 85 | 98 | 103 | 132 |
| Total Assets | 82 | 93 | 94 | 106 | 111 | 146 |
Cash Flow
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | — | 2 | 9 | -1 | 9 | -18 |
| Investing | — | -2 | -2 | 0 | -2 | -7 |
| Financing | — | 0 | -7 | 2 | -6 | 26 |
| Net Cash Flow | — | 0 | 0 | 0 | 0 | 2 |
| Free Cash Flow | — | 1 | 8 | -1 | 7 | -24 |
| CFO/OP | — | 37 | 105 | 3 | 71 | -94 |
Ratios
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor Days | 352 | 280 | 230 | 204 | 198 | 205 |
| Inventory Days | 55 | 120 | 177 | 263 | 272 | 212 |
| Days Payable | 30 | 85 | 75 | 37 | 29 | 22 |
| Cash Conversion Cycle | 377 | 315 | 332 | 430 | 441 | 395 |
| Working Capital Days | 348 | 274 | 255 | 256 | 275 | 361 |
| ROCE % | — | 7% | 10% | 15% | 14% | 13% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Sheel Biotech insights
53 extracted metrics + investor summaries across FY21–FY26.
Documents
1
General Updates
25 Sep - Sheel Biotech Limited has informed about General Updates 25 Sep - Sheel Biotech Limited has informed about General Updates
2
Shareholders meeting
25 Sep - 35th AGM resolutions passed unanimously, including land sale approval and related party transactions. 25 Sep - 35th AGM resolutions passed unanimously, including land sale approval and related party transactions.
3
Shareholders meeting
25 Sep - Sheel Biotech Limited has informed regarding voting results of Annual General Meeting held on September 24, 2026 25 Sep - Sheel Biotech Limited has informed regarding voting results of Annual General Meeting held on September 24, 2026
4
Trading Window
25 Sep - Sheel Biotech Limited has informed regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 25 Sep - Sheel Biotech Limited has informed regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
5
Shareholders meeting
24 Sep - Sheel Biotech Limited has informed regarding Proceedings of Annual General Meeting held on September 24, 2026 24 Sep - Sheel Biotech Limited has informed regarding Proceedings of Annual General Meeting held on September 24, 2026
Frequently Asked Questions about Sheel Biotech
What does Sheel Biotech Ltd do?
Incorporated in November 1994, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects.[1]
Where is Sheel Biotech Ltd (SHEEL) listed?
Sheel Biotech Ltd trades as SHEEL on the NSE.
Which sector does Sheel Biotech Ltd belong to?
Sheel Biotech Ltd is classified under the Commercial Services sector, in the Diversified Services industry.
What is the market capitalisation of Sheel Biotech Ltd?
Sheel Biotech Ltd has a market capitalisation of ₹122.12 Cr as of 8 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Sheel Biotech Ltd?
Over the last 52 weeks Sheel Biotech Ltd has traded between ₹37.8 and ₹92.8 as of 8 Oct 2026.
What is the Return on Equity (ROE) of Sheel Biotech Ltd?
Sheel Biotech Ltd reported a return on equity of 9.26%. Its debt-to-equity ratio is 0.07.
Company Information
Incorporated in November 1994, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SHEEL.md for Sheel Biotech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.